FDA
New sedative for dogs is launched
Dechra’s alpha-2 combination drug is indicated to minimize stress surrounding canine sedation
FDA grants conditional approval for drug delaying start of congestive heart failure in canines
This chewable tablet is the first drug on the market for delaying the onset of Stage B2 preclinical myxomatous mitral valve disease in canines
FDA accepting 2023 grant applications for animal drugs for minor uses and minor species
Pharmaceutical sponsors who meet the eligibility requirements or their research partners are encouraged to apply.
New antibiotic for cattle and swine is available
Tulathromycin injection is an option for bovine respiratory disease, and other conditions
ACANA hairball control food receives FDA approval
The new dry cat food that will alleviate feline hairballs is now available in stores
Novel plant-based drug now available for the treatment of chemotherapy-induced diarrhea in dogs
Jaguar Animal Health’s crofelemer product has conditional approval from the FDA
Draft guidance for use of published literature to support new animal drug approvals announced by FDA
The document expands upon the original guidance #106 by considering various uses of the scientific literature to support approval of a new animal drug
Final guidance on animal drug compounding from bulk drug substances issued by the FDA
The agency will provide outreach and education as part of its’ implementation plan.
3 Must-reads on recent FDA approvals
3 articles highlighting the latest FDA-approved veterinary drugs
FDA approves new combination injection for sedation and pain relief in dogs
The drug product is a balanced combination of medetomidine and vatinoxan.